JP2005538690A - 腫瘍の治療用の自己ワクチンの調製のための長いペントラキシンｐｔｘ３機能性誘導体 - Google Patents

腫瘍の治療用の自己ワクチンの調製のための長いペントラキシンｐｔｘ３機能性誘導体 Download PDF

Info

Publication number
JP2005538690A
JP2005538690A JP2003571309A JP2003571309A JP2005538690A JP 2005538690 A JP2005538690 A JP 2005538690A JP 2003571309 A JP2003571309 A JP 2003571309A JP 2003571309 A JP2003571309 A JP 2003571309A JP 2005538690 A JP2005538690 A JP 2005538690A
Authority
JP
Japan
Prior art keywords
ptx3
derivative
seq
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003571309A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005538690A5 (cg-RX-API-DMAC7.html
Inventor
リタ・デ・サンティス
ジョヴァンニ・サルヴァトーリ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of JP2005538690A publication Critical patent/JP2005538690A/ja
Publication of JP2005538690A5 publication Critical patent/JP2005538690A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4756—Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2003571309A 2002-02-28 2003-02-25 腫瘍の治療用の自己ワクチンの調製のための長いペントラキシンｐｔｘ３機能性誘導体 Pending JP2005538690A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002RM000109A ITRM20020109A1 (it) 2002-02-28 2002-02-28 Derivati funzionali della pentraxina lunga ptx3 per preparare un vaccino autologo per la cura dei tumori.
PCT/IT2003/000104 WO2003072603A2 (en) 2002-02-28 2003-02-25 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours

Publications (2)

Publication Number Publication Date
JP2005538690A true JP2005538690A (ja) 2005-12-22
JP2005538690A5 JP2005538690A5 (cg-RX-API-DMAC7.html) 2006-04-06

Family

ID=11456119

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003571309A Pending JP2005538690A (ja) 2002-02-28 2003-02-25 腫瘍の治療用の自己ワクチンの調製のための長いペントラキシンｐｔｘ３機能性誘導体

Country Status (12)

Country Link
US (1) US20090110666A1 (cg-RX-API-DMAC7.html)
EP (1) EP1478661A2 (cg-RX-API-DMAC7.html)
JP (1) JP2005538690A (cg-RX-API-DMAC7.html)
KR (1) KR20040099291A (cg-RX-API-DMAC7.html)
AR (1) AR038854A1 (cg-RX-API-DMAC7.html)
AU (1) AU2003214645A1 (cg-RX-API-DMAC7.html)
CA (1) CA2475526A1 (cg-RX-API-DMAC7.html)
IT (1) ITRM20020109A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA04008217A (cg-RX-API-DMAC7.html)
PL (1) PL372719A1 (cg-RX-API-DMAC7.html)
TW (1) TWI293958B (cg-RX-API-DMAC7.html)
WO (1) WO2003072603A2 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20040858A1 (it) 2004-04-29 2004-07-29 Farma Dev S R L Anticorpi monoclonali ibridomi metodo migliorato per determinare la proteina ptx3 e kit per detta determinazione
ITRM20040489A1 (it) 2004-10-08 2005-01-08 Sigma Tau Ind Farmaceuti Pentraxina lunga ptx3 deglicosilata o desialidata.
JP5427415B2 (ja) * 2006-01-24 2014-02-26 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ Ｆｇｆ２結合性ペプチドおよびそれらの使用
US8435525B1 (en) * 2010-04-16 2013-05-07 Andrew B. Bush FGF modulation of in vivo antibody production and humoral immunity
US9226960B2 (en) * 2010-04-16 2016-01-05 Andrew B. Bush FGF modulation of in vivo antibody production and humoral immunity
TWI531375B (zh) 2015-05-29 2016-05-01 國立成功大學 抑制癌細胞活性之短肽治療劑及含此之醫藥組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849478A (en) * 1986-08-14 1998-12-15 Cashman; Daniel P. Blocked-polymerase polynucleotide immunoassay method and kit
US5290551A (en) * 1990-05-08 1994-03-01 Thomas Jefferson University Treatment of melanoma with a vaccine comprising irradiated autologous melanoma tumor cells conjugated to a hapten
IT1298487B1 (it) * 1997-12-19 2000-01-10 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale,
IT1317927B1 (it) * 2000-11-03 2003-07-15 Sigma Tau Ind Farmaceuti Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie autoimmuni.
IT1317930B1 (it) * 2000-11-08 2003-07-15 Sigma Tau Ind Farmaceuti Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patalogie associate ad una alterata attivazione
US20020122820A1 (en) * 2001-01-16 2002-09-05 Hildebrand William H. Soluble MHC artificial antigen presenting cells
US7041648B2 (en) * 2001-08-03 2006-05-09 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Compositions and methods for treating female fertility
ES2261714T3 (es) * 2001-08-03 2006-11-16 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Uso de la pentraxina larga ptx3 para tratar la infertilidad femenina.
ITRM20020191A1 (it) * 2002-04-08 2003-10-08 Sigma Tau Ind Farmaceuti Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie tumorali associate ad una alterata att
US20040137544A1 (en) * 2002-10-31 2004-07-15 Roberto Latini PTX3 as an early prognostic indicator of cardiovascular and cerebrovascular pathologies
ITRM20030596A1 (it) * 2003-12-23 2005-06-24 Sigma Tau Ind Farmaceuti Uso di inibitori della pentraxina lunga ptx3, per la preparazione di un medicamento per la prevenzione e cura di patologie che rispondono all'inibizione dell'attivita' biologica di detta ptx3.
US20070023879A1 (en) * 2005-07-29 2007-02-01 Vinayak Pandey Single unit heat sink, voltage regulator, and package solution for an integrated circuit

Also Published As

Publication number Publication date
TW200303755A (en) 2003-09-16
WO2003072603A2 (en) 2003-09-04
ITRM20020109A1 (it) 2003-08-28
TWI293958B (en) 2008-03-01
US20090110666A1 (en) 2009-04-30
MXPA04008217A (es) 2004-11-26
AU2003214645A1 (en) 2003-09-09
AU2003214645A8 (en) 2003-09-09
PL372719A1 (en) 2005-07-25
WO2003072603A3 (en) 2004-03-18
EP1478661A2 (en) 2004-11-24
WO2003072603A9 (en) 2004-10-07
CA2475526A1 (en) 2003-09-04
AR038854A1 (es) 2005-01-26
KR20040099291A (ko) 2004-11-26
ITRM20020109A0 (it) 2002-02-28

Similar Documents

Publication Publication Date Title
CN100590131C (zh) 用于将蛋白定向到胞外体的方法和化合物
JP4723722B2 (ja) ワクチン用アジュバントとしてのｍｈｃクラスｉｉリガンドの使用および癌治療におけるｌａｇ−３の使用
US10688165B2 (en) Medicament for use in a method of inducing or extending a cellular cytotoxic immune response
EP2231180B1 (en) Vaccine for alzheimer's disease
JP2024036364A (ja) Ｉ型インターフェロン遺伝子を刺激するための方法及びカチオン性脂質を含む組成物
DE60128070T2 (de) Impfstoff spezifisch gegen nierentumore, gerichtet gegen das antigen g-250 des nierentumors
JP7633930B2 (ja) 抗癌ワクチンのための共有腫瘍抗原としてのｈｅｒｖ－ｋ由来抗原
CN118355037A (zh) Ccl13的用途
JP4138073B2 (ja) ヒト癌退縮抗原タンパク質
JP2005538690A (ja) 腫瘍の治療用の自己ワクチンの調製のための長いペントラキシンｐｔｘ３機能性誘導体
KR102297440B1 (ko) 표적 세포 특이적으로 결합하여 다중 면역기능이 강화된 키메라항원 및 이의용도
CN111150841B (zh) 一种主动免疫调控微粒及其制备方法和应用
CA2440610C (en) Induction of tumor immunity by variants of folate binding protein
JP2024161435A (ja) Ｍｈｃおよび腫瘍抗原を同時発現する抗原提示細胞を含む組成物およびこれを用いた癌治療
US20040022813A1 (en) Shed antigen vaccine with dendritic cells adjuvant
CN110168086B (zh) 疟疾疫苗
JP2007537143A (ja) アンジオモチンまたはアンジオモチンをコードするポリヌクレオチドを含むワクチン組成物、および、ワクチン組成物の血管新生に関連した病気の治療のための使用
EP4346883A1 (en) Methods of treating or preventing autoimmune diseases
JP2006516258A (ja) ワクチンおよび抗腫瘍ワクチンを調製する方法
WO2007081301A2 (en) Methods and compositions related to the identification of a novel il-12 inducing protein isolated from toxoplasma gondii
JPWO2003000894A1 (ja) ポリヌクレオチドワクチン
JP7513303B2 (ja) 腫瘍免疫増強剤、その調製方法および適用
US6514493B1 (en) cDNA clone for tumor rejection antigen gp110 and tumor peptide vaccine
CN116948005A (zh) 一种病毒递送的新型细胞因子及在肿瘤治疗中的应用
JP4231284B2 (ja) Ｓｙｔ−ｓｓｘ改変ペプチド

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060220

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060220

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080924

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081222

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090507